Literature DB >> 18443121

Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.

Te-Li Chen1, Roy Chen-Chih Wu, Men-Fang Shaio, Chang-Phone Fung, Wen-Long Cho.   

Abstract

The oxacillinase gene was reported to confer limited resistance to carbapenem in Acinetobacter baumannii. In this study, we have demonstrated that an A. baumannii clinical isolate harboring a plasmid, pTVICU53, has 11,037 bp encoding 13 open reading frames. A bla(OXA-58) gene with an upstream insertion of truncated ISAba3 (DeltaISAba3) and IS1008 was found in this plasmid. DeltaISAba3and IS1008 provided two independent promoters for the transcription control of the bla(OXA-58) gene. The transformation of pTVICU53 or a shuttle vector bearing IS1008-DeltaISAba3-bla(OXA-58) to different A. baumannii recipients can increase their MICs of carbapenem 64- to 256-fold. The deletion of promoters provided by IS1008 resulted in dramatic decreases in bla(OXA-58) transcription and a 32- to 64-fold reduction in the carbapenem MIC. These findings highlight that A. baumannii might develop carbapenem resistance with a single transformation step, taking up a plasmid containing a genetic construct with a potentially high level of transcription of the bla(OXA-58) gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443121      PMCID: PMC2443897          DOI: 10.1128/AAC.00393-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

Review 1.  Multiresistant acinetobacter in the UK: how big a threat?

Authors:  J Coelho; N Woodford; J Turton; D M Livermore
Journal:  J Hosp Infect       Date:  2004-11       Impact factor: 3.926

2.  Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii.

Authors:  Siham Mahgoub; Jimmie Ahmed; Aaron E Glatt
Journal:  Am J Infect Control       Date:  2002-11       Impact factor: 2.918

3.  Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates.

Authors:  Yu Mi Lim; Kyeong Seob Shin; Jungmin Kim
Journal:  J Clin Microbiol       Date:  2006-12-27       Impact factor: 5.948

4.  Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance.

Authors:  Adriana S Limansky; María Alejandra Mussi; Alejandro M Viale
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii.

Authors:  Felipe Fernández-Cuenca; Luis Martínez-Martínez; Maria Carmen Conejo; Juan A Ayala; Evelio J Perea; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

6.  Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system.

Authors:  Isabelle Marchand; Laurence Damier-Piolle; Patrice Courvalin; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.

Authors:  M Gehrlein; H Leying; W Cullmann; S Wendt; W Opferkuch
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

8.  Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay.

Authors:  Richard E Rothman; Maulik D Majmudar; Gabor D Kelen; Guillermo Madico; Charlotte A Gaydos; Tarik Walker; Thomas C Quinn
Journal:  J Infect Dis       Date:  2002-11-06       Impact factor: 5.226

9.  An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.

Authors:  Wensi S Hu; Shu-Man Yao; Chang-Phone Fung; Yi-Ping Hsieh; Chang-Pan Liu; Jing-Fang Lin
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

10.  Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Cheng-Yi Chen; Wen-Hwei Chen; Chong-Jen Yu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more
  33 in total

1.  A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii.

Authors:  Yangsoon Lee; Chang-Ki Kim; Hyukmin Lee; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  ISAba825, a functional insertion sequence modulating genomic plasticity and bla(OXA-58) expression in Acinetobacter baumannii.

Authors:  Pablo Ravasi; Adriana S Limansky; Ramiro E Rodriguez; Alejandro M Viale; María A Mussi
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

Review 3.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

4.  Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection.

Authors:  Yu-Ting Liao; Shu-Chen Kuo; Yi-Tzu Lee; Chien-Pei Chen; Shu-Wen Lin; Li-Jiuan Shen; Chang-Phone Fung; Wen-Long Cho; Te-Li Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii.

Authors:  Yi-Tzu Lee; Shu-Chen Kuo; Mei-Chun Chiang; Su-Pen Yang; Chien-Pei Chen; Te-Li Chen; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

6.  Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia.

Authors:  Ya-Sung Yang; Yung-Chih Wang; Shu-Chen Kuo; Chung-Ting Chen; Chang-Pan Liu; Yuag-Meng Liu; Te-Li Chen; Yi-Tzu Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

7.  Class D β-lactamases: are they all carbapenemases?

Authors:  Nuno T Antunes; Toni L Lamoureaux; Marta Toth; Nichole K Stewart; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

8.  Acinetobacter baumannii Extracellular OXA-58 Is Primarily and Selectively Released via Outer Membrane Vesicles after Sec-Dependent Periplasmic Translocation.

Authors:  Yu-Ting Liao; Shu-Chen Kuo; Ming-Hsien Chiang; Yi-Tzu Lee; Wang-Chou Sung; You-Hsuan Chen; Te-Li Chen; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

9.  Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.

Authors:  Yi-Tzu Lee; Yung-Chih Wang; Shu-Chen Kuo; Chung-Ting Chen; Chang-Pan Liu; Yuag-Meng Liu; Te-Li Chen; Ya-Sung Yang
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

10.  A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.

Authors:  Raffaele Zarrilli; Domenico Vitale; Anna Di Popolo; Maria Bagattini; Ziad Daoud; Asad U Khan; Claude Afif; Maria Triassi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.